2016

11426 bookmarks
Newest
Build Apps with AI in Minutes | Base44
Build Apps with AI in Minutes | Base44
From idea to live app in minutes. Base44 gives you the tools to launch fully-functional apps - no code, no setup, no hassle.
·base44.com·
Build Apps with AI in Minutes | Base44
Neuroprotective and Anti-Inflammatory Activity of Undaria pinnatifida Fucoidan In Vivo—A Proteomic Investigation - PMC
Neuroprotective and Anti-Inflammatory Activity of Undaria pinnatifida Fucoidan In Vivo—A Proteomic Investigation - PMC
Undaria pinnatifida fucoidan (UPF), a bioactive sulphated polysaccharide, is widely recognised for its anti-inflammatory, antioxidant, antitumor, anticoagulant, antiviral, and immunomodulatory properties. However, the precise mechanisms by which UPF ...
·pmc.ncbi.nlm.nih.gov·
Neuroprotective and Anti-Inflammatory Activity of Undaria pinnatifida Fucoidan In Vivo—A Proteomic Investigation - PMC
Anti-Inflammatory and Neuroprotective Effects of Undaria pinnatifida Fucoidan[v1] | Preprints.org
Anti-Inflammatory and Neuroprotective Effects of Undaria pinnatifida Fucoidan[v1] | Preprints.org
Undaria pinnatifida fucoidan (UPF), a sulphated polysaccharide derived from brown seaweed, has attracted increasing scientific interest for its wide-ranging anti-inflammatory and neuroprotective properties. Previous studies have demonstrated that UPF exerts significant anti-inflammatory effects through the downregulation of pro-inflammatory cytokines, inhibition of key signalling pathways such as NF-κB and MAPKs, suppression of oxidative stress, and modulation of immune mediators and gut microbiota. In parallel, emerging evidence highlights UPF's neuroprotective potential, characterised by reduced neuroinflammation, oxidative damage, and amyloid-beta accumulation, alongside enhanced antioxidant defence and neuronal function. Current investigations reinforce these findings, suggesting that UPF may serve as a valuable adjunct in managing inflammation-related disorders and neurodegenerative conditions. This review summarises the current knowledge on UPF’s mechanisms of action, with a particular focus on its anti-inflammatory and neuroprotective pathways and implications for brain health, while also identifying gaps for future research and clinical translation.
·preprints.org·
Anti-Inflammatory and Neuroprotective Effects of Undaria pinnatifida Fucoidan[v1] | Preprints.org
Analysis of Polar Lipids in Hemp (Cannabis sativa L.) By-Products by Ultra-High Performance Liquid Chromatography and High-Resolution Mass Spectrometry - PMC
Analysis of Polar Lipids in Hemp (Cannabis sativa L.) By-Products by Ultra-High Performance Liquid Chromatography and High-Resolution Mass Spectrometry - PMC
Polar lipids were extracted from residual biomass of hemp (Cannabis sativa L.) by-products with EtOH and partitioned into aqueous and chloroform fractions. The chloroform fractions were studied for their lipid composition using solid-phase ...
·pmc.ncbi.nlm.nih.gov·
Analysis of Polar Lipids in Hemp (Cannabis sativa L.) By-Products by Ultra-High Performance Liquid Chromatography and High-Resolution Mass Spectrometry - PMC
William Makis MD on X: "NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 78 year old Nebraska PARKINSON'S DISEASE patient of 8 years, cured after 4 months! My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in https://t.co/p7qtTiDRTC" / X
William Makis MD on X: "NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 78 year old Nebraska PARKINSON'S DISEASE patient of 8 years, cured after 4 months! My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in https://t.co/p7qtTiDRTC" / X
My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in
·x.com·
William Makis MD on X: "NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 78 year old Nebraska PARKINSON'S DISEASE patient of 8 years, cured after 4 months! My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in https://t.co/p7qtTiDRTC" / X
Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson's disease - PubMed
Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson's disease - PubMed
Gut microbiome alterations are linked to various diseases, including neurodegeneration, but their ecological and functional impacts remain unclear. Using integrated multi-omics (metagenomics and metatranscriptomics), we analyse microbiome gene co-expression networks in Parkinson's disease (PD) and h …
·pubmed.ncbi.nlm.nih.gov·
Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson's disease - PubMed
The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review - PMC
The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review - PMC
Researchers are increasingly focusing on understanding the microbiota’s influence on disease susceptibility and overall health. The vast number of microorganisms in our gastrointestinal tract and their extensive surface area underscore their ...
·pmc.ncbi.nlm.nih.gov·
The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review - PMC
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease - PMC
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease - PMC
The biomarkers of Parkinson’s disease (PD) remain to be investigated. This work aimed to identify blood biomarkers for PD using targeted metabolomics analysis. We quantified the plasma levels of 255 metabolites in 92 PD patients and 60 healthy ...
·pmc.ncbi.nlm.nih.gov·
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease - PMC